Evidence map›Paper›PMID 21209212›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2011

Phosphoinositide 3-kinase-dependent antagonism in mammalian olfactory receptor neurons.

Kirill Ukhanov, Daniela Brunert, Elizabeth A Corey, Barry W Ache

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Melatonin promotes sleep by activating the BK channel inProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Presynaptic inhibition by α2 receptor/adenylate cyclase/PDE4 complex at retinal rod bipolar synapse.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Kirill UkhanovWhitney Laboratory, Center for Smell and Taste, and McKnight Brain Institute, University of Florida, Gainesville, Florida 32610, USA. ukhanov@mbi.ufl.edu
Daniela Brunert
Elizabeth A Corey
Barry W Ache
Taste and Smell Clinic · USUniversity of Florida · USWhitney Museum of American Art · US

Funding

MULTIPLE PATHWAYS IN OLFACTORY TRANSDUCTIONR01DC001655 · NIDCD · UNIVERSITY OF FLORIDA · PI ACHE, BARRY W. · 1992 to 2010
$3.0M
Phosphoinositide Signaling in Mammalian OlfactionR01DC005995 · NIDCD · UNIVERSITY OF FLORIDA · PI ACHE, BARRY W. · 2003 to 2015
$3.0M
New approaches to phosphoinositide signaling in olfaction.F32DC009730 · NIDCD · UNIVERSITY OF FLORIDA · PI COREY, ELIZABETH A · 2008 to 2011
$157k
NIDCD NIH HHS DC001655NIDCD NIH HHS DC005995NIDCD NIH HHS DC009730NIDCD NIH HHS F32 DC009730NIDCD NIH HHS R01 DC001655NIDCD NIH HHS R01 DC005995
6 · The paper itself

Abstract

Phosphoinositide signaling, in particular, phosphoinositide 3-kinase (PI3K) signaling, has been implicated in mediating inhibitory odorant input to mammalian olfactory receptor neurons (ORNs). To better understand this phenomenon we investigated PI3K-dependent inhibition between single odorant pairs. The concentration-dependent inhibition of the response of native rat ORNs to octanol by citral is PI3K dependent; blocking PI3K activity with the β and γ isoform-specific inhibitors AS252424 (5-[5-(4-fluoro-2-hydroxy-phenyl)-furan-2-ylmethylene]-thiazolidine-2,4-dione) and TGX221(7-methyl-2-(4-morpholinyl)-9-[1-(phenylamino)ethyl]-4H-pyrido [1,2-a]pyrimidin-4-one) eliminated or strongly reduced the inhibition. Interestingly, blocking PI3K also changed the apparent agonist strength of the otherwise noncompetitive antagonist citral. The excitation evoked by citral after blocking PI3K, could be suppressed by the adenylate cyclase III (ACIII) blockers MDL12330A (cis-N-(2-phenylcyclopentyl)-azacyclotridec-1-en-2-amine hydrochloride) and SQ22536 [9-(tetrahydro-2-furanyl)-9H-purin-6-amine], indicating that citral could also activate ACIII, presumably through the canonical olfactory receptor (OR). The G-protein G(β)γ subunit blockers suramin (8,8'-[carbonylbis[imino-3,1-phenylen ecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid), gallein (3',4',5',6'-tetrahydroxyspiro[isobenzofuran-1(3H),9'-(9H)xanthen]-3-one), and M119 (cyclohexanecarboxylic acid [2-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)-(9CI)]) suppressed citral's inhibition of the response to octanol, indicating that the activation of PI3K by citral was G-protein dependent, consistent with the idea that inhibition acts via the canonical OR. Lilial similarly antagonized the response to isoamyl acetate in other ORNs, indicating the effect generalizes to at least one other odorant pair. The ability of methyl-isoeugenol, limonene, α-pinene, isovaleric acid, and isosafrole to inhibit the response of other ORNs to IBMX (3-isobutyl-1-methylxanthine)/forskolin in a PI3K-dependent manner argues the effect generalizes to yet other structurally dissimilar odorants. Our findings collectively raise the interesting possibility that the OR serves as a molecular logic gate when mammalian ORNs are activated by natural, complex mixtures containing both excitatory and inhibitory odorants.

Indexed as

Phosphoinositide-3 Kinase InhibitorsAcyclic MonoterpenesAnimalsCalciumCyclohexanesDose-Response Relationship, DrugDrug InteractionsEnzyme InhibitorsModels, BiologicalMonoterpenesOdorantsOlfactory MucosaOlfactory Receptor NeuronsPhosphatidylinositol 3-KinasesRatsRats, Sprague-DawleyAcyclic MonoterpenesCalciumcitralCyclohexanesEnzyme InhibitorsgalleinM119 compoundMonoterpenesPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsSuraminXanthenes

Identifiers

PMID21209212
PMCPMC3079265
OpenAlexW1997825411

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.